Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David B Beck

Showing results (31-40 of 83) with videos related to

Pageof 9
Sort By:
The Lancet. Rheumatology|September 7, 2025
Mapping the infectious burden in VEXAS syndrome: a systematic review and rationale for preventionValentine Ribier, Jérôme Hadjadj, Vincent Jachiet, et al.
Blood Advances|October 14, 2021
A clinical, histopathological, and molecular study of two cases of VEXAS syndrome without a definitive myeloid neoplasmPeng Li, Shobi Venkatachalam, Daniela Ospina Cordona, et al.
Journal of Proteome Research|October 15, 2014
In vivo proximity labeling for the detection of protein-protein and protein-RNA interactionsDavid B Beck, Varun Narendra, William J Drury, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 10, 2023
Novel Somatic UBA1 Variant in a Patient With VEXAS SyndromeBlanka Stiburkova, Katerina Pavelcova, Monika Belickova, et al.
American Journal of Clinical Pathology|May 26, 2025
Rapid clinical deployment of UBA1 testing in patients with VEXAS syndromePaul A Wadsworth, Simon B Chen, Lauren Lawrence, et al.
Blood Advances|July 21, 2023
Use of flow cytometric light scattering to recognize the characteristic vacuolated marrow cells in VEXAS syndromeYanna Ding, Alina E Dulau-Florea, Emma M Groarke, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 6, 2021
VEXAS Syndrome: A Case Series From a Single-Center Cohort of Italian Patients With VasculitisFrancesco Muratore, Chiara Marvisi, Paola Castrignanò, et al.
Rheumatology (Oxford, England)|November 25, 2025
Establishing a consensus definition of VEXAS flare for clinical researchLachelle D Weeks, Danielle Hammond, Sinisa Savic, et al.
Nature Communications|July 26, 2023
A ubiquitin-based effector-to-inhibitor switch coordinates early brain, craniofacial, and skin developmentAnthony J Asmar, Shaun R Abrams, Jenny Hsin, et al.
Frontiers in Immunology|April 3, 2019
Second Case of HOIP Deficiency Expands Clinical Features and Defines Inflammatory Transcriptome Regulated by LUBACHirotsugu Oda, David B Beck, Hye Sun Kuehn, et al.
Pageof 9

Showing results (31-40 of 83) with videos related to

Sort By:
Pageof 9
The Lancet. Rheumatology|September 7, 2025
Mapping the infectious burden in VEXAS syndrome: a systematic review and rationale for preventionValentine Ribier, Jérôme Hadjadj, Vincent Jachiet, et al.
Blood Advances|October 14, 2021
A clinical, histopathological, and molecular study of two cases of VEXAS syndrome without a definitive myeloid neoplasmPeng Li, Shobi Venkatachalam, Daniela Ospina Cordona, et al.
Journal of Proteome Research|October 15, 2014
In vivo proximity labeling for the detection of protein-protein and protein-RNA interactionsDavid B Beck, Varun Narendra, William J Drury, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 10, 2023
Novel Somatic UBA1 Variant in a Patient With VEXAS SyndromeBlanka Stiburkova, Katerina Pavelcova, Monika Belickova, et al.
American Journal of Clinical Pathology|May 26, 2025
Rapid clinical deployment of UBA1 testing in patients with VEXAS syndromePaul A Wadsworth, Simon B Chen, Lauren Lawrence, et al.
Blood Advances|July 21, 2023
Use of flow cytometric light scattering to recognize the characteristic vacuolated marrow cells in VEXAS syndromeYanna Ding, Alina E Dulau-Florea, Emma M Groarke, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 6, 2021
VEXAS Syndrome: A Case Series From a Single-Center Cohort of Italian Patients With VasculitisFrancesco Muratore, Chiara Marvisi, Paola Castrignanò, et al.
Rheumatology (Oxford, England)|November 25, 2025
Establishing a consensus definition of VEXAS flare for clinical researchLachelle D Weeks, Danielle Hammond, Sinisa Savic, et al.
Nature Communications|July 26, 2023
A ubiquitin-based effector-to-inhibitor switch coordinates early brain, craniofacial, and skin developmentAnthony J Asmar, Shaun R Abrams, Jenny Hsin, et al.
Frontiers in Immunology|April 3, 2019
Second Case of HOIP Deficiency Expands Clinical Features and Defines Inflammatory Transcriptome Regulated by LUBACHirotsugu Oda, David B Beck, Hye Sun Kuehn, et al.
Pageof 9